IMPACT (Improving Patient Access to Cancer Testing) grant program
IMPACT (Improving Patient Access to Cancer Testing) grant program supports patient advocacy organizations’ work to improve access to genomic testing and help people affected by cancer understand their results.
Browse similar grants
Funder: Illumina
Due Dates: Not listed
Funding Amounts: Not listed
Summary: Targeted funding for patient advocacy initiatives that improve access to genomic testing for people affected by cancer.
Key Information: The program partners with patient advocacy organizations.
Description
Illumina’s IMPACT (Improving Patient Access to Cancer Testing) grant program partners with patient advocacy organizations to break down barriers to genomic testing and empower communities affected by cancer. It provides targeted funding for initiatives that raise awareness of genomics in cancer care, address challenges that limit access to testing, and help patients and families understand and act on their results.
IMPACT is part of Illumina’s broader grants and sponsorships work supporting efforts aligned with its mission to unlock the power of the genome and advance genomics. This program focuses specifically on patient access to and understanding of genomic testing.
